•Explain the basic features of opioid dependency as outlined by the DSM 5
•Recognize the patient with an opioid use disorder (OUD) and decide if opioid replacement therapy (ORT) with Buprenorphine is appropriate and safe for that patient.
•Initiate treatment with Buprenorphine adhering to prescribed induction protocols.
•Watch for common and uncommon adverse events seen with buprenorphine/naloxone and potential drug interactions.
•Evaluate the stability of a patient on ORT with Buprenorphine using the clinical interview and urine drug screen (UDS)
Presenters: Dr. Peter Barnes, MD; Dr. Stephen Darcy, MD Dr. Bruce Hollett, MD
Registration Fee: $100
This is a half day session. Accreditation (8 CME hours)
Funded by an unrestricted educational grant from the Clinical Stabilization Fund, Newfoundland and Labrador Medical Association
For more information, please contact: Martha.email@example.com
REGISTER HERE: www.nlma.nl.ca/nlma/forms/sad